These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 18035065

  • 1. Ceramide and glucosylceramide upregulate expression of the multidrug resistance gene MDR1 in cancer cells.
    Gouazé-Andersson V, Yu JY, Kreitenberg AJ, Bielawska A, Giuliano AE, Cabot MC.
    Biochim Biophys Acta; 2007 Dec; 1771(12):1407-17. PubMed ID: 18035065
    [Abstract] [Full Text] [Related]

  • 2. Expression of P-glycoprotein in HeLa cells confers resistance to ceramide cytotoxicity.
    Chapman JV, Gouazé-Andersson V, Cabot MC.
    Int J Oncol; 2010 Dec; 37(6):1591-7. PubMed ID: 21042729
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
    Chapman JV, Gouazé-Andersson V, Karimi R, Messner MC, Cabot MC.
    Exp Cell Res; 2011 Jul 15; 317(12):1736-45. PubMed ID: 21396934
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.
    Gouazé V, Yu JY, Bleicher RJ, Han TY, Liu YY, Wang H, Gottesman MM, Bitterman A, Giuliano AE, Cabot MC.
    Mol Cancer Ther; 2004 May 15; 3(5):633-9. PubMed ID: 15141021
    [Abstract] [Full Text] [Related]

  • 6. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi).
    Zhang X, Li J, Qiu Z, Gao P, Wu X, Zhou G.
    Cancer Biol Ther; 2009 Jun 15; 8(12):1117-21. PubMed ID: 19502811
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MDR1 (multidrug resistence 1) can regulate GCS (glucosylceramide synthase) in breast cancer cells.
    Zhang X, Wu X, Li J, Sun Y, Gao P, Zhang C, Zhang H, Zhou G.
    J Surg Oncol; 2011 Oct 15; 104(5):466-71. PubMed ID: 21538359
    [Abstract] [Full Text] [Related]

  • 9. P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway.
    Turzanski J, Grundy M, Shang S, Russell N, Pallis M.
    Exp Hematol; 2005 Jan 15; 33(1):62-72. PubMed ID: 15661399
    [Abstract] [Full Text] [Related]

  • 10. Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling.
    Liu YY, Gupta V, Patwardhan GA, Bhinge K, Zhao Y, Bao J, Mehendale H, Cabot MC, Li YT, Jazwinski SM.
    Mol Cancer; 2010 Jun 11; 9():145. PubMed ID: 20540746
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.
    Shabbits JA, Mayer LD.
    Mol Cancer Ther; 2002 Jan 11; 1(3):205-13. PubMed ID: 12467215
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
    Liu YY, Han TY, Giuliano AE, Cabot MC.
    J Biol Chem; 1999 Jan 08; 274(2):1140-6. PubMed ID: 9873062
    [Abstract] [Full Text] [Related]

  • 15. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1.
    Zhao L, Jin X, Xu Y, Guo Y, Liang R, Guo Z, Chen T, Sun Y, Ding X.
    J Exp Clin Cancer Res; 2010 Jul 19; 29(1):98. PubMed ID: 20642825
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance.
    Liu YY, Han TY, Giuliano AE, Hansen N, Cabot MC.
    J Biol Chem; 2000 Mar 10; 275(10):7138-43. PubMed ID: 10702281
    [Abstract] [Full Text] [Related]

  • 18. Trametenolic acid B reverses multidrug resistance in breast cancer cells through regulating the expression level of P-glycoprotein.
    Zhang Q, Wang J, He H, Liu H, Yan X, Zou K.
    Phytother Res; 2014 Jul 10; 28(7):1037-44. PubMed ID: 25289403
    [Abstract] [Full Text] [Related]

  • 19. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J, Xia M, Liu W, Li L, Yang J, Mei Y, Meng Q, Xie Y.
    Eur J Pharmacol; 2019 Jun 05; 852():231-243. PubMed ID: 30959046
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.